Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

Clinical trial NCT05409235 · COMPLETED

Trial details

NCT number: NCT05409235
Sponsor: OcuTerra Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Retinopathy

Start date: 2022-07-29
Primary completion: 2023-12-29
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.